These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. International normalized ratio and anticoagulation. Theerman MR Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971 [No Abstract] [Full Text] [Related]
3. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? Caine GJ; Lip GY Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973 [No Abstract] [Full Text] [Related]
4. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Meyer G; Marjanovic Z; Valcke J; Lorcerie B; Gruel Y; Solal-Celigny P; Le Maignan C; Extra JM; Cottu P; Farge D Arch Intern Med; 2002 Aug 12-26; 162(15):1729-35. PubMed ID: 12153376 [TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J; Goodin S J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108 [TBL] [Abstract][Full Text] [Related]
6. Practical application of the 10-mg warfarin initiation nomogram. Wells PS; Le Gal G; Tierney S; Carrier M Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation quality and the risk of recurrence of venous thromboembolism. Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D Thromb Haemost; 2007 Nov; 98(5):1148-50. PubMed ID: 18000626 [No Abstract] [Full Text] [Related]
8. [Thrombosis in spite of warfarin--what should be done?]. Lassila R Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826 [No Abstract] [Full Text] [Related]
9. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?]. MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994 [No Abstract] [Full Text] [Related]
10. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism. Tran HA N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126 [No Abstract] [Full Text] [Related]
12. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants. DeLoughery TG Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670 [TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of catheter-related thrombosis in cancer patients. Prandoni P Lancet; 2009 Feb; 373(9663):523-4. PubMed ID: 19217973 [No Abstract] [Full Text] [Related]
15. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices. Lee AY Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267 [No Abstract] [Full Text] [Related]